Literature DB >> 13423210

Two A antigens with abnormal serologic properties.

J J VAN LOGHEM, H DORFMEIER, M VAN DER HART.   

Abstract

Keywords:  BLOOD GROUPS

Mesh：

Substances：

Year:  1957        PMID： 13423210     DOI： 10.1111/j.1423-0410.1957.tb03429.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  12 in total

1.  ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.

Authors:  J I BRODY; L H BEIZER
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

2.  [Blood groups and leukemia].

Authors:  E R GOLD; L HOLLANDER
Journal:  Blut       Date:  1963-05

3.  Enzymatic and nonezymatic alterations of erythrocyte surface antigens.

Authors:  G F SPRINGER
Journal:  Bacteriol Rev       Date:  1963-06

4.  [A further example of weak A property (Am)].

Authors:  M KINDLER
Journal:  Blut       Date:  1958-12

5.  Erythrocyte serology of some malignant diseases.

Authors:  G W Bird
Journal:  Blut       Date:  1977-09-29

6.  Mosaicism by somatic non-functional mutations: one cell lineage at a time.

Authors:  Willy Albert Flegel
Journal:  Haematologica       Date:  2019-03       Impact factor: 9.941

7.  [Studies of the erythrocyte population in leukemias deviating from ABO antigenicity].

Authors:  A Májsky; T Hraba; A Bártová; V Chudomel; M Poslusná
Journal:  Blut       Date:  1965-07

8.  Suppression of A and I antigens in a case of chronic myelogenous leukemia.

Authors:  M Yokoyama
Journal:  Blut       Date:  1969-01

Review 9.  [Various current problems in the study of blood groups (protectins)].

Authors:  O Prokop
Journal:  Klin Wochenschr       Date:  1969-06-01

10.  DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients.

Authors:  Tina Bianco-Miotto; Damian J Hussey; Tanya K Day; Denise S O'Keefe; Alexander Dobrovic
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.